ARTICLES BY THIS AUTHOR
- 2/21/2022
Nexus gains FDA nod for generic Erythrocin
The medication is indicated in the treatment of infections caused by susceptible strains of designated organisms in certain diseases when oral administration is not possible. - 2/21/2022
GSK’s proposed health spinoff to be named Haleon
Haleon will have a world-class portfolio of category leading global brands, including Sensodyne, Voltaren, Panadol and Centrum, the company said. - 2/17/2022
Kroger’s delivery service lands in Oklahoma
The retailer’s new fulfillment center in Oklahoma City will deliver orders in a temperature-controlled delivery van that can store up to 20 orders. - 2/17/2022
Aurobindo obtains FDA nod for generic Lanoxin
Digoxin tablets have a market value of roughly $2.1 million for the 12 months ending December 2021, according to IQVIA. - 2/17/2022
RangeMe adds direct purchasing to product discovery platform
RangeMe will continue rolling out the platform to retailers and suppliers in the United States across all major CPG categories throughout the year. - 2/17/2022
Dollar Tree announces retirement of executive chairman
Bob Sasser’s retirement follows a tenure with the company of more than 20 years, during which he aided Dollar Tree’s growth in the value retail sector. - 2/17/2022
Amring intros generic Lamictal
Lamotrigine ODT is indicated for epilepsy adjunctive therapy in patients aged 2 years old and older, epilepsy monotherapy in patients aged 16 years old and older, and maintenance of bipolar I disorder. - 2/16/2022
Zydus given FDA OK for generic Daliresp
Roflumilast tablets are indicated as a treatment to reduce the risk of COPD exacerbations in patients with severe COPD associated with chronic bronchitis and a history of exacerbations. - 2/16/2022
EnlivenHealth’s patient-engagement solution aims to mitigate staffing shortages
EnlivenHealth’s personalized IVR is reducing phone interruptions by up to 15% and freeing up pharmacists, according to the company. - 2/16/2022
Walmart reports strong Q4, full-year earnings
Walmart shared that it expects adjusted earnings per share growth in the mid-single digits for the fiscal year 2023.